glp-1/gcgr dual agonist Media Centre Triple GLP-1 / GIP /
Description
Diabetes Obes Metab 2013;15:770-3.ArticlePubMed 113
"Without concerted action, these medicines could contribute to widening the gap between the rich and poor, both between and within countries." A new generation of appetite-suppressing drugs called GLP-1 agonists -- which includes blockbuster brands Ozempic and Mounjaro -- has become massively popular in recent years
Spencer JP, Thomas S, Trondsen Pawlowski RH
2015, Smith et al
However, while promising , its long-term effects on OSA outcomes beyond weight loss require further study
